Clinical Trial Update: Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating thymosin in combination with pegylated interferon for non-cirrhotic hepatitis C patients who did not respond to interferon o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: Hepatitis C, Hepatitis C, Chronic | Phase 3 | Status: COMPLETED